scholarly journals Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high‐risk donor seropositive/recipient seronegative heart transplant recipients

2020 ◽  
Vol 22 (3) ◽  
Author(s):  
Hannah Imlay ◽  
Allison O. Dumitriu Carcoana ◽  
Cynthia E. Fisher ◽  
Beatrice Wong ◽  
Robert M. Rakita ◽  
...  
Keyword(s):  
High Risk ◽  
Heart Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Heart Transplant Recipients

Incidence and Clinical Features of Ganciclovir- Resistant Cytomegalovirus Disease in Heart Transplant Recipients

2007 ◽  
Vol 45 (4) ◽  
pp. 439-447 ◽  
Author(s):  
F. Li ◽  
K. W. Kenyon ◽  
K. A. Kirby ◽  
D. P. Fishbein ◽  
M. Boeckh ◽  
...  
Keyword(s):  
Clinical Features ◽  
Heart Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Heart Transplant Recipients

scholarly journals High Risk of Graft Failure in Emerging Adult Heart Transplant Recipients

2015 ◽  
Vol 15 (12) ◽  
pp. 3185-3193 ◽  
Author(s):  
B. J. Foster ◽  
M. Dahhou ◽  
X. Zhang ◽  
V. Dharnidharka ◽  
V. Ng ◽  
...  
Keyword(s):  
High Risk ◽  
Heart Transplant ◽  
Graft Failure ◽  
Emerging Adult ◽  
Transplant Recipients ◽  
Adult Heart ◽  
Heart Transplant Recipients

One Year Follow-up of Heart Transplant Recipients after Oral Ganciclovir Prophylaxis Against Cytomegalovirus Disease.

1999 ◽  
Vol 67 (7) ◽  
pp. S39
Author(s):  
G. M. Mullen ◽  
K. Malinowska ◽  
C. E. Lawless ◽  
B. A. Pisani ◽  
J. C. Mendez ◽  
...  
Keyword(s):  
Heart Transplant ◽  
Oral Ganciclovir ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Heart Transplant Recipients ◽  
One Year
Sign in / Sign up

Export Citation Format

Share Document